Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2019 1
2020 3
2021 10
2022 8
2023 5
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

29 results

Results by year

Filters applied: . Clear all
Page 1
Sjögren's syndrome: one year in review 2022.
Manfrè V, Chatzis LG, Cafaro G, Fonzetti S, Calvacchi S, Fulvio G, Navarro Garcia IC, La Rocca G, Ferro F, Perricone C, Bartoloni E, Baldini C. Manfrè V, et al. Among authors: chatzis lg. Clin Exp Rheumatol. 2022 Dec;40(12):2211-2224. doi: 10.55563/clinexprheumatol/43z8gu. Epub 2022 Dec 20. Clin Exp Rheumatol. 2022. PMID: 36541236 Free article. Review.
Sjögren's syndrome: one year in review 2023.
Longhino S, Chatzis LG, Dal Pozzolo R, Peretti S, Fulvio G, La Rocca G, Navarro Garcia IC, Orlandi M, Quartuccio L, Baldini C, Bartoloni E. Longhino S, et al. Among authors: chatzis lg. Clin Exp Rheumatol. 2023 Dec;41(12):2343-2356. doi: 10.55563/clinexprheumatol/255qsx. Epub 2023 Dec 23. Clin Exp Rheumatol. 2023. PMID: 38149515 Free article. Review.
One year in review 2021: Sjögren's syndrome.
Cafaro G, Bursi R, Chatzis LG, Fulvio G, Ferro F, Bartoloni E, Baldini C. Cafaro G, et al. Among authors: chatzis lg. Clin Exp Rheumatol. 2021 Nov-Dec;39 Suppl 133(6):3-13. doi: 10.55563/clinexprheumatol/eojaol. Epub 2021 Dec 1. Clin Exp Rheumatol. 2021. PMID: 34874834 Free article. Review.
New frontiers in precision medicine for Sjogren's syndrome.
Chatzis L, Vlachoyiannopoulos PG, Tzioufas AG, Goules AV. Chatzis L, et al. Expert Rev Clin Immunol. 2021 Feb;17(2):127-141. doi: 10.1080/1744666X.2021.1879641. Epub 2021 Feb 5. Expert Rev Clin Immunol. 2021. PMID: 33478279 Review.
Liver Fibrosis in Primary Sjögren's Syndrome.
Androutsakos T, Voulgaris TA, Bakasis AD, Koutsompina ML, Chatzis L, Argyropoulou OD, Pezoulas V, Fotiadis DI, Papatheodoridis G, Tzioufas AG, Goules AV. Androutsakos T, et al. Among authors: chatzis l. Front Immunol. 2022 Jun 15;13:889021. doi: 10.3389/fimmu.2022.889021. eCollection 2022. Front Immunol. 2022. PMID: 35784296 Free PMC article.
Combined seronegativity in Sjögren's syndrome.
Chatzis LG, Pezoulas V, Voulgari PV, Baldini C, Exarchos TP, Fotiadis DI, Mavragani CP, Skopouli FN, Moutsopoulos HM, Tzioufas AG, Goules AV. Chatzis LG, et al. Clin Exp Rheumatol. 2021 Nov-Dec;39 Suppl 133(6):80-84. doi: 10.55563/clinexprheumatol/47a4kr. Epub 2021 Oct 4. Clin Exp Rheumatol. 2021. PMID: 34665703 Free article.
High-content multimodal analysis supports the IL-7/IL-7 receptor axis as a relevant therapeutic target in primary Sjögren's syndrome.
Desvaux E, Hemon P, Soret P, Le Dantec C, Chatzis L, Cornec D, Devauchelle-Pensec V; PRECISESADS clinical consortium; Elouej S, Duguet F, Laigle L, Poirier N, Moingeon P, Bretin S, Pers JO. Desvaux E, et al. Among authors: chatzis l. J Autoimmun. 2023 Dec 18:103147. doi: 10.1016/j.jaut.2023.103147. Online ahead of print. J Autoimmun. 2023. PMID: 38114349
29 results